04:51 PM EST, 01/27/2025 (MT Newswires) -- Christopher Peetz, Director, CEO, on January 23, 2025, sold 6,837 shares in Mirum Pharmaceuticals ( MIRM ) for $327,658. Following the Form 4 filing with the SEC, Peetz has control over a total of 333,592 shares of the company, with 125,022 shares held directly and 208,570 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1759425/000141588925002134/xslF345X05/form4-01272025_090100.xml